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Receptor engagement by HIV-1 during host cell entry
activates signaling pathways that can reprogram the
cell for optimal viral replication. To obtain a global
view of the signaling events induced during HIV-1
entry, we conducted a quantitative phosphoproteo-
mics screen of primary human CD4+ T cells after
infection with an HIV-1 strain that engages the recep-
tors CD4 and CXCR4.We quantified 1,757 phosphor-
ylation sites with high stringency. The abundance
of 239 phosphorylation sites from 175 genes,
including several proteins in pathways known to be
impacted by HIV-receptor binding, changed signifi-
cantly within a minute after HIV-1 exposure. Several
previously uncharacterized HIV-1 host factors were
also identified and confirmed throughRNAi depletion
studies. Surprisingly, five serine/arginine-rich (SR)
proteins involved in messenger RNA splicing,
including the splicing factor SRm300 (SRRM2),
were differentially phosophorylated. Mechanistic
studies with SRRM2 suggest that HIV-1 modulates
host cell alternative splicing machinery during entry
in order to facilitate virus replication and release.
INTRODUCTION
Viruses rely not only on host molecules to successfully infect and
replicate in new cells, but often directly manipulate cellular pro-
cesses to facilitate more efficient virus replication. Vaccinia virus
(Mercer and Helenius, 2008), herpes viruses (Soroceanu et al.,
2008), and enteroviruses (Coyne and Bergelson, 2006) induce
signaling cascades resulting from viral engagement of cell-sur-
face receptors that can induce the internalization of viral particles
and facilitate viral replication. Many studies have contributed to
the growing list of cellular host factors that are required for viral
replication; however, relatively little is known of the full extent to
which viruses can facilitate their entry and replication by manip-
ulating host signal-transduction pathways.Cell HHIV-1 primarily infects CD4+ T cells in vivo. The gp120 subunit
of the viral envelope protein first engages CD4, then binds to one
of two chemokine receptors, CCR5 or CXCR4 (Wilen et al.,
2012). These interactions enable the viral envelope protein to un-
dergo the conformational changes needed to elicit fusion be-
tween the viral and host cell membranes, and also result in signal
transduction via CD4 and the CCR5 or CXCR4 coreceptors that
can enhance T cell activation and virus replication (Briant et al.,
1996; Davis et al., 1997). More specifically, HIV-regulated phos-
phorylation of cofilin (Yoder et al., 2008), moesin (Barrero-Villar
et al., 2009), filamin (Jime´nez-Baranda et al., 2007), and LARG
(Hodges et al., 2007) during entry can modulate various early
steps of viral replication. Whether these or other virus-induced
signaling events enhance later steps of the HIV-1 life cycle is
not well understood.
Given the growing list of virus-induced cellular signaling
events that can influence entry and replication, we hypothesized
that uncovering signaling events resulting from HIV-host cell
interactions would reveal additional HIV-1 host factors. Using
mass spectrometry (MS)-based phosphoproteomics in combi-
nation with stable isotope labeling by amino acids in cell culture
(SILAC), we quantified 1,757 phosphorylation sites with high
stringency in primary human CD4+ T cells during entry of an
HIV-1 strain that engages CD4 and CXCR4. We found that
239 phosphorylation sites from 175 genes significantly changed
in abundance within 1 min of exposure to HIV-1, including
several proteins in signaling pathways that are known to be
impacted by HIV-receptor binding. Unexpectedly, we found
that five serine/arginine-rich (SR) proteins involved in
messenger RNA (mRNA) splicing were differentially phoso-
phorylated in T cells upon HIV-receptor engagement. These
included nine phosphorylation sites in the splicing factor
SRm300 (SRRM2), a cellular protein without previously
described functional links to HIV-1 replication. We found that
suppression of SRRM2 with RNAi in Jurkat and MAGI cell lines
enhanced HIV-1 gene expression only when virions containing
Env proteins that engage CXCR4 were used. In addition,
SRRM2 modulated alternative splicing of HIV-1 transcripts
and was required for efficient virion release. These findings
show that HIV-1 induced signaling events are far more extensive
than previously suspected and that by inducing signaling path-
ways, HIV-1 can reprogram cells to not only enhance entry, butost & Microbe 13, 613–623, May 15, 2013 ª2013 Elsevier Inc. 613
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Figure 1. Phosphoproteomics Workflow
(A) Phosphoproteomics workflow for T cell stimu-
lations, processing, and fractionation. Virus- and
mock-treated samples were independently pro-
cessed following mixing with a common reference
lysate. HIV and mock phosphorylation site fold
changes were calculated by dividing the ratio of
reference/mock by reference/HIV phosphorylation
site fold changes. The abbreviations used are
as follows: light, L; heavy, H; hydrophilicity inter-
action liquid chromatography, HILIC; immobilized
metal affinity chromatography, IMAC; and liquid
chromatography tandem mass spectrometer, LC/
MS/MS.
(B) Primary CD4+ T cells were incubated with pu-
rified HIV-1 or a mock vesicle preparation for
various lengths of time at 37C and probed for
phosphorylated p38 (pT180/pY182) by immuno-
blot for determining the optimal kinetics for large-
scale phosphoproteomics stimulations.
(C) Distribution of phosphorylation site fold
changes. HIV and mock phosphorylation site fold
changes are shown according to the mixture-
model designation of HIV responsive (red) or HIV
nonresponsive, i.e., null (blue). For clarity, only a
subset of SRm300-responsive phosphorylation
sites is indicated.
See also Figure S1.
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splicing, more efficient as well.
RESULTS
SILAC-Based Quantitative Phosphoproteomics in
Nondividing Primary CD4+ T Cells
To identify signaling events induced soon after HIV-1 engage-
ment of cell-surface receptors, we titrated highly purified HIV-1
MN—a virus strain that utilizes CD4 and CXCR4—on unstimu-
lated primary human CD4+ T cells. A mock virus preparation,
produced from the same cells and in the same manner as the vi-
rus, was used as a negative control. We reasoned that the rela-
tively quiescent state of these cells makes it possible to monitor
virus-induced signaling events that might otherwise be masked
following the potent in vitro stimulation regimes that are
commonly used tomaximize virus infection. To synchronize virus
binding, we added a high concentration of virus at 37C in order
to obtain a sufficient number of binding events within a very short
time frame. Using cells from multiple donors, we found that the
addition of 20 mg/ml of viral p24 (15 nM gp120) to unstimulated
CD4+ T cells for 1 min yielded optimal phosphorylation of
mitogen-activated protein kinase (MAPK) p38, a known HIV-
responsive phosphorylation site (data not shown and Figure 1B)
(Furler and Uittenbogaart, 2010). We used these conditions to
study early signaling events induced by HIV-1 upon binding to
the cell surface.
To quantify relative fold changes of phosphorylation sites with
MS, we used SILAC. Given that unstimulated T cells do not have
sufficient metabolic activity for complete isotope labeling, we
labeled the human CD4+ T cell line CEM with media containing614 Cell Host & Microbe 13, 613–623, May 15, 2013 ª2013 Elsevier I13C and 15N arginine and lysine so as to construct a ‘‘heavy’’
isotope reference proteome (Geiger et al., 2011). Lysates from
mock or virus-treated T cells were then independently mixed
with this common reference lysate, making it possible to mea-
sure the fold change in abundance of any phosphopeptide that
was identified in the mock, virus-treated, and reference pro-
teomes (Figure 1A). Importantly, the distribution of SILAC ratios
for each referencemixture was unimodal, and over 90%of ratios
were 7.2-fold or less, suggesting that the reference phosphopro-
teome sufficiently represented the primary cell phosphopro-
teome (Figure S1 available online). Following several filtering
steps, 1,757 phosphorylation sites (from 799 genes) were quan-
tified with high stringency in the mock-reference and HIV-refer-
ence samples (Figure S1; Tables S1–S3). At a 1% false discovery
rate threshold, a total of 239 phosphorylation sites (from 175
genes) were deemed HIV responsive, with 144 increasing and
95 decreasing in abundance upon HIV-1 treatment (Figure 1C;
Tables S3 and S4).
HIV-Induced Phosphorylation of the Transcription
Factor ETS
We took several approaches to validate the SILAC phosphoryla-
tion site ratios, with the most direct being the use of phospho-
specific antibodies. Unfortunately, only two antibodies for the
identified HIV-responsive phosphorylation sites, p38 (pT180/
pY182) and ETS-1 (pS282/pS285), worked sufficiently well by
immunoblot to make this analysis possible. We used each to
assess changes in their respective phoshosites via immunoblot
following the addition of purifiedHIV-1 to CD4+ T cells. Enhanced
p38 phophorylation (pT180/pY182) upon the addition of HIV-1
for 1 min was confirmed (Figure 2A), as was HIV-inducednc.
AB
C
upregulated
downregulated
Figure 2. Immunoblot and Bioinformatic Validation of HIV-Respon-
sive Phosphorylation Site Ratios
(A) Primary CD4+ T cells were incubated with purified HIV-1 or a mock vesicle
preparation and probed for phosphorylated p38 (pT180/pY182), ETS-1
(pS282/pS285), and ERK1/2 (pT202/pY204) by immunoblot. The chemokine
CXCL12 (SDF-1) served as a positive control for pERK1/2. OR and p values
were calculated with Fisher’s exact text with Benjamini and Hochberg cor-
rections.
(B) Putative kinase substrate motifs were searched for within up- or down-
regulated HIV-responsive phosphorylation sites. The amino-acid-position-
weighted matrix, centered on phosphorylated serine (position 0), is shown for
each top-scoring motif.
(C) Overrepresentation of the CaMKII and PKA motifs within HIV up- and
downregulated phosphorylation sites was calculated with the Fisher’s exact
test; each p value is indicated above each bar. f, L/V/I/M/Y/F; pS, phospho-
serine.
See also Table S4.
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confirmed that the kinase ERK1/2 was not phosphorylated in
anHIV-dependent manner, though it was responsive to CXCL12.
Phosphoproteome-wide Validation of HIV-Induced
MAPK Activity
To further validate the HIV-responsive phosphorylation site ra-
tios, we took advantage of the fact that differential phosphoryla-Cell Htion is in part regulated by changes in the catalytic activity of
upstream kinases. Because we observed robust phosphoryla-
tion of p38 (pT180/pY182), but not of ERK1/2 (pT202/pY204),
upon addition of HIV-1 to CD4+ T cells (Figure 2A), we hypothe-
sized that HIV-responsive phosphorylation sites should contain
an overrepresentation of p38-dependent, but not ERK1/2-
dependent, phosphorylation sites. To examine this, we took
advantage of p38 and ERK1/2-responsive phosphorylation sites
as defined by Pan et al. (2009). We then measured the overrep-
resentation of these p38 or ERK1/2-dependent phosphorylation
sites within HIV-responsive phosphorylation sites with the
Fisher’s exact test. Only p38-dependent phosphorylation sites
were significantly overrepresented among HIV-responsive phos-
phorylation sites (odds ratio [OR]: 6.7, p = 2.03 106 versus OR:
1.5, p = 0.52) (Figure 2A; Table S4), supporting the fact that, in
both immunoblot and SILAC analysis, the addition of HIV-1 to
CD4+ T cells leads to rapid phosphorylation of p38 phosphoryla-
tion sites that are known to enhance its kinase activity.
Identification of Overrepresented Kinase Substrate
Motifs
To determine whether HIV-1 activated additional kinases, we
took advantage of the fact that the phosphorylation of many ki-
nase substrates is highly influenced by the amino acids that
immediately surround the phosphorylation site. Therefore, we
surveyed the amino acid residues surrounding each HIV-respon-
sive phosphorylation site using the Group-based Prediction Sys-
tem (GPS) (Xue et al., 2011) and motif extractor (motif-x) tool
(Schwartz and Gygi, 2005). The GPS uses a hierarchical algo-
rithm to rank the likelihood that a particular kinase or kinase fam-
ily phosphorylates a given phosphorylation site, whereas motif-x
measures the overrepresentation of amino acid sequence pat-
terns, providing an unbiased list of potential kinase substrate
motifs. With the GPS tool, substrates for MAPKAPK were signif-
icantly overrepresented according to the Fisher’s exact test (OR:
7.3, p = 6.13 106) (Table S4). Members of theMAPKAPK family
are known substrates for p38 (Cargnello and Roux, 2011), which
is rapidly activated upon HIV-1 binding to CD4+ T cells
(Figure 1B).
The motif-x tool revealed that the [R/K]xxS motif, which dis-
played a bias toward hydrophobic amino acids at the P  5
and P + 1 positions (fx[R/K]xxSf), was significantly overrepre-
sented among upregulated HIV-responsive phosphorylation
sites (OR: 13.2, p = 1.1 3 107) (Figures 2B and 2C; Table S4).
This motif is one of many that are targets for calmodulin-depen-
dent kinase II (CaMKII) (Schwartz and Gygi, 2005). CaMKII activ-
ity is regulated by fluxes in free Ca2+ levels, and HIV-1 gp120
induces a transient Ca2+ flux in primary CD4+ T cells (Weissman
et al., 1997). These data, combined with the fact that the HIV-
responsive phosphorylation site ETS-1 (pS282/pS285) is phos-
phorylated by CaMKII (Fisher et al., 1994), support an increase
in CaMKII activity during HIV-1 entry. For the downregulated
HIV-responsive phosphorylation site motifs, RRxS matches the
consensus motif for protein kinase A (PKA), [R/K][R/K]xS (OR:
7.5, p = 5.1 3 1011) (Figures 2B and 2C; Table S4). PKA kinase
activity is regulated by intracellular levels of the second
messenger, cyclic AMP (cAMP) (Mosenden and Taske´n, 2011).
The observed decrease in phosphorylated PKA substrates is
supported by the observation that gp120 treatment of primaryost & Microbe 13, 613–623, May 15, 2013 ª2013 Elsevier Inc. 615
AB
Figure 3. Bioinformatic Analysis of Genes
from HIV-Responsive Phosphorylation Sites
(A) Interaction network of HIV-responsive phos-
phoproteins. Functional or physical interactions
(see Experimental Procedures) between genes
from HIV-responsive phosphosites were extracted
from the STRING database (version 9.0). Under-
lined genes indicate SR proteins. Genes indicated
as ‘‘HIV-1 replication’’ were taken from Table 1.
(B) HIV-1 host factors are overrepresented within
HIV-responsive phosphoproteins. Overlaps of
genes from HIV-responsive phosphoproteins and
genes from the HHPID, HIV-1 RNAi screens, and
West Nile virus (WNV) siRNA screen were calcu-
lated with the hypergeometric test using the hu-
man genome as a background (n = 20,402).
See also Table S6.
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HIV Reprograms the Cellular PhosphoproteomeCD4+ T cells decreases cAMP levels within minutes and that
cAMP is a negative regulator of HIV-1 replication in primary cells
(Navarro et al., 1998).
Cellular Pathways
To gauge which cellular pathways HIV-1 may activate during en-
try, we tested whether HIV-responsive phosphoproteins con-
tained an overrepresentation of gene ontology or cellular
pathway terms from manually curated databases. The most
notable ontologies and pathways involved various aspects of
GTPase biology, actin, and T cell activation (Table S5). Strength-
ening the association with T cell activation, upregulated T cell re-
ceptor-responsive phosphorylation sites from both Jurkat
(Mayya et al., 2009) (OR: 19.2, p = 0.039) and primary CD4+
T cells (Ruperez et al., 2012) (OR: 4.3, p = 8.73 105) were over-
represented amongHIV-responsive phosphorylation sites (Table
S4). We also generated an interaction network using the STRING
(Search Tool for the Retrieval of Interacting Genes/Proteins)
database (Figure 3A) and found a striking segregation between
cytoplasmic- and nuclear-localized genes and discreet func-616 Cell Host & Microbe 13, 613–623, May 15, 2013 ª2013 Elsevier Inc.tional modules of genes that regulate mi-
crotubules, actin, and T cell activation—
all processes that have clear links to
HIV-1 biology (Figure 3A) (Liu et al.,
2009; Stevenson et al., 1990). The fact
that the majority of genes that regulate
T cell activation also regulate actin further
strengthens the association between
these processes and HIV-induced
signaling (Liu et al., 2009).
Because our hypothesis is that HIV-
responsive phosphoproteins are impor-
tant for HIV-1 infection and replication,
we measured whether there was an over-
representation of previously defined HIV-
1 host factors within our data set. The
HIV-1 human protein interaction data-
base (HHPID) is a manually curated list
of both physical and functional interac-
tions between HIV-1 and human proteins
(Fu et al., 2009). The overlap with theHHPID data set was highly significant (hypergeometric test,
p = 3.8 3 1015) (Figure 3B; Table S6). In addition, the overlap
with genes from the four published HIV-1 RNAi screens (Brass
et al., 2008; Ko¨nig et al., 2008; Krishnan et al., 2008; Yeung
et al., 2009) was also significant (hypergeometric test, p =
1.33 104), but the overlap with a small interfering RNA (siRNA)
screen conducted with West Nile virus was not significant
(Krishnan et al., 2008) (p = 0.49) (Figure 3B; Table S6). These
overlaps, combined with literature mining, resulted in a total of
84/175 genes from HIV-responsive phosphorylation sites having
been previously described as HIV-1 host factors (Table S6), sup-
porting our hypothesis that HIV-responsive phosphoproteins are
involved in HIV-1 infection.
Role of HIV-Responsive Phosphoproteins during HIV-1
Infection
To examine whether HIV-responsive phosphoproteins regulate
HIV-1 infection, we depleted 69 of the 175 genes from HIV-
responsive phosphosites using siRNAs (four per gene) in MAGI
cells and measured the infection levels of three full-length
Table 1. HIV-Responsive Phosphoproteins that Impact HIV-1
Replication in MAGI Cells
Gene Symbol Cellular Pathway
Previously Linked
to HIV?a
ACIN1 apoptosis yes
AHNAK T cell activation
ANXA2 actin yes (+)
ARHGEF18 actin
ARHGEF7 actin yes
BUD13 splicing
CRTC3 cyclic AMP yes (+)
DBN1 actin yes (+)
DBNL actin
DIDO1 apoptosis
DNM1L apoptosis, T cell activation yes
DOCK11 actin
EVL actin, T cell activation yes
FKBP15 actin
GORASP2 vesicle trafficking yes (+)
KHDRBS1 splicing, NF-kB yes (+)
KIAA1967 chromatin yes
KIF2A microtubules
LSM14A splicing
MAP4 microtubules yes (+)
MTDH NF-kB yes
NCK1 actin, T cell activation yes
NCL ribosome synthesis yes (+)
NUP88 nuclear transport yes
PAG1 T cell activation
PAK2 actin yes
PNN splicing yes
PPIG transcription
RAF1 NF-kB yes (+)
RANBP2 HIV integration site selection yes (+)
RAPGEF6 NF-kB yes (+)
REPS1 vesicle trafficking
RNF31 transcription
SH3BP1 actin
TBC1D10B vesicle trafficking
TBC1D5 vesicle trafficking
WIPF1 actin
A subset (n = 69) of HIV-responsive phosphoproteins was depleted in
MAGI cells, then infected with replication-competent HIV-1. Genes are
shown whose depletion led to an at least 2-fold decrease in infection
with three out of four siRNAs tested.
a(+) indicates reported functional link between HIV-1 replication and
gene. See also Table S8.
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bles S7 and S8).We deemed a gene important for HIV-1 infection
if at least three out of four siRNAs decreased MAGI cell b-galac-
tosidase reporter activity by 2-fold (compared to a nontargeting
siRNA) in at least one IMC; 37 genes satisfied this criteria (Table
1). Although roughly half of these genes have been previouslyCell Hlinked to HIV-1 biology in some way, 27 have not yet been func-
tionally linked to HIV-1 to our knowledge (Tables 1 and S8).
Cellular pathways such as actin, microtubules, T cell activation,
and various nuclear processes such as splicing were heavily rep-
resented, further linking known aspects of HIV-1 signaling and
our phosphoproteomics data set (Figure 3A; Table 1).
To address whether HIV-responsive phosphoproteins are
important for HIV-1 infection, we selected four HIV-responsive
phosphoproteins, MYCPB2, OSBPL11, SCYL2, and SRRM2,
on the basis of an identical phosphorylation site that was both
HIV and CXCL12 reponsive (Wojcechowskyj et al., 2011).
CXCL12 is the chemokine ligand for CXCR4, which is the recep-
tor used by the HIV-1 strain in our study. We depleted each pro-
tein with four individual siRNAs per gene inMAGI cells (Figure 4B)
and with pools of siRNAs in Jurkat cells (Figure 4C). We then in-
fected depleted cells with a single-cycle HIV-1 reporter virus
bearing either an X4 - or R5-tropic Env or the glycoprotein of ve-
sicular stomatitis virus G protein (VSV-G). As expected, treat-
ment with CD4-specific siRNAs inhibited infection by HIV-1,
but not VSV; the siRNAs to CXCR4 only inhibited infection by
the X4 virus strain; and the siRNAs to IGSF3 (an irrelevant gene
for HIV-1 infection) had no effect on any virus (Figure 4A). Among
the experimental samples, only suppression of SRRM2 consis-
tently enhanced HIV-1 reporter gene expression in both MAGI
and Jurkat cells (Figures 4A and 4D). We also measured the frac-
tion of virus-infected MAGI cells via intracellular p24 staining of
NL4.3 and 89.6 IMC or GFP expression and found that suppres-
sion of SRRM2 had no consistent effect on the permissivity of
cells to HIV-1 infection (Figure 4E). Therefore, we conclude that
suppression of SRRM2 results in higher levels of HIV-1 gene
expression per infected cell; thus, we focused on the possible
role of SRRM2 in HIV-1 infection in subsequent experiments.
Regulation of HIV-1 Alternative Splicing and Infection by
SRRM2
SRRM2 encodes SRm300, an SR protein that contains two char-
acteristic arginine-serine (RS) domains (Figure S2). SR proteins
are central regulators of cellular splicing whose activity can be
modulated by phosphorylation of RS domains (Long and
Caceres, 2009). Of the 37 unique phosphorylation site ratios in
SRm300 that we were able to quantify, nine were HIV responsive
(Figure S2; Table S3). During HIV-1 infection, dozens of fully and
partially spliced viral mRNAs are generated through a complex
interplay between viral and cellular elements, of which many of
the latter are cellular SR proteins (Stoltzfus, 2009). To address
whether SRRM2 regulates HIV-1 alternative splicing, we specif-
ically amplified fully spliced transcripts frommRNA isolated from
SRRM2-depleted MAGI cells that were infected with LAI or VSV-
G pseudovirions or with the primary IMC, 89.6 (Figure 5A). A
representative gel is shown for 89.6, with the corresponding
exon composition of each transcript. For all viruses, depletion
of SRRM2 led to an approximately 2-fold increase in the
ratio of tat-2/tat-1 and nef-3/nef-2 transcripts (Figure 5B). The ra-
tio of tat-3/tat-1 and nef-4/nef-2 also increased with 89.6, yet we
were not able to clearly resolve tat-3 and nef-4 with the pseudo-
virions. We conclude that SRRM2 regulates the inclusion of
exons 2 and 3, perhaps by modulating the strength of the splice
acceptors A1 and A2. Unexpectedly, LAI pseudovirions had an
average of 1.8 times less nef-3 relative to nef-2 than VSV-Gost & Microbe 13, 613–623, May 15, 2013 ª2013 Elsevier Inc. 617
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Figure 4. RNAi-Mediated Knockdown of HIV-Responsive Phosphoproteins
(A) MAGI cells were transfected with individual siRNAs, then infected with NL4.3 pseudovirions with an X4-tropic Env, R5-tropic Env, or VSV-G. Infection values
(luciferase activity) were normalized to a nontargeting control siRNA.
(B) Lysates from depleted MAGI cells were analyzed by immunoblot (top panel). SRm300 protein levels were monitored by FACS (bottom panel): gray area,
nontargeting control; solid line, siRNA#1; dotted line, siRNA#2; short dashed line, siRNA#3; long dashed line, siRNA#4.
(C) Jurkat cells were nucleofected with indicated pools of siRNA and analyzed by immunoblot (top panel). SRm300 protein levels were monitored by FACS
(bottom panel): gray area, nontargeting control; solid line, SRm300 pool.
(D) Nucleofected Jurkat cells were infected as in (A). Bars represent SEM; n = 3.
(E) Relative percent infection of SRm300-depleted MAGI cells with replication-competent 89.6, NL4.3, and GFP-expressing VSV-G pseudovirions. Bars
represent SEM; n = 4; *p < 0.05 Mann-Whitney; ns, not significant (p > 0.05).
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gesting that signals induced by HIV-1 Env may themselves influ-
ence alternative splicing.
The balance of HIV-1 splicing products is finely tuned and
highly dependent on an overlapping, interconnected network
of diverse of cis and trans factors, which in turn can affect HIV-
1 replication (Stoltzfus, 2009). Consistent with reports that
increased splicing at A1 and A2 leads to decreased virus produc-
tion (Jacquenet et al., 2005), we observed up to a 6- and 30-fold
reduction in p24 release upon infection with 89.6 and NL4.3,
respectively, in three out of four siRNAs targeting SRRM2 (Fig-
ure 5C). We also tested four additional siRNAs against SRRM2
and observed the same increase in tat and nef alternatively-
spliced transcripts and the same impact on virion release
(Figure S4). When the fold-change magnitudes of tat and nef618 Cell Host & Microbe 13, 613–623, May 15, 2013 ª2013 Elsevier Itranscripts were correlated with p24 release for all siRNAs tested
(n = 8), the correlation with nef-4 was statistically significant (p =
0.022, Spearman’s correlation coefficient) (Table S9), suggest-
ing that SRRM2-dependent dysregulation of nef-4 transcript
abundance is most tightly linked to productive HIV-1 infection.
Regulation of HIV-1 Alternative Splicing and Infection by
HIV-Responsive SR Proteins
Five other SR proteins, PNN, PPIG, TRA2A, ACIN1, and SRRM1,
were also HIV-responsive phosphoproteins, leading us to hy-
pothesize that they too are important for HIV-1 splicing. We
depleted each with pools of siRNAs in MAGI cells and measured
fully spliced HIV-1 transcripts (Figure 6A). Depletion of all SR pro-
teins except PPIG led to a unique HIV-1 splicing pattern. Deple-
tion of PNN led to increases in all exon 2- and 3-containing tatnc.
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Figure 5. SRRM2 Regulates Alternative
Splicing of HIV-1
(A) RT-PCR analysis of HIV-1 transcripts. Exon
compositions of sequence-confirmed transcripts
are indicated to the right of a representative 89.6
DNA gel, positioned with respect to the HIV-1
genome above. D1–D4: 50 splice sites. A1–A7: 30
splice sites.
(B) Relative quantification of HIV-1 transcripts.
Band intensities of corresponding RT-PCR prod-
ucts of tat and nef alternatively spliced products
were divided by tat-1 and nef-2, respectively.
Comparisons were made between each SRRM2
siRNA and the nontargeting control siRNA.
(C) HIV-1 release following depletion of SRRM2 as
measured by p24 collected on day 5 post infection.
Comparisons were made between each SRRM2
siRNA and the nontargeting control siRNA. Bars
represent SEM; n = 4; *p < 0.05 Mann-Whitney; ns,
not significant (p > 0.05).
See also Figure S2.
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PNN regulates the inclusion of exons 2 and 3 only in the context
of tat transcription (Figure 6B). A similar pattern of tat transcripts
was seen with TRA2A (Figure 6B). Depletion of ACIN1 led to a
dramatic increase in tat-4 and tat-3 transcripts and a corre-
sponding decrease in all nef transcripts, making quantification
of nef transcripts difficult (Figure 6B). Depletion of SRRM1, a
binding partner of SRRM2, led to increases in tat-2 and nef-3,
but not tat-3 and nef-4 (Figure 6B). This suggests that SRRM1
regulates the activity of site A1, but not A2, in both tat and nef
transcripts and that SRRM1 and SRRM2 may modulate HIV-1
splicing in both overlapping and distinct protein complexes.
DISCUSSION
Viral infection is intimately tied to interactions with host proteins
and pathways that facilitate virtually every step of the virus life
cycle. By binding to and crosslinking cell-surface molecules, vi-
ruses can induce intracellular signaling cascades that can
enhance the permissiveness of the host cell to infection. The re-Cell Host & Microbe 13, 613–ceptors used by HIV-1 to enter cells are
well-known signaling molecules and
important immune modulators. Binding
of Env to these receptors results in down-
stream phosphorylation events and the
modulation of various intracellular second
messengers; however, the breadth of HIV-
induced signaling cascades, their tempo-
ral relationship to virus infection, and the
roles that these signaling events play in
specific aspects of virus infection are far
from well characterized.
We employed unstimulated CD4+
T cells, because these most closely
reflect the major cell type encountered
by HIV-1 in vivo and because a growing
body of evidence indicates that virus-
induced signaling events play a signifi-cant role in virus infection of primary T cells. We used an
X4-tropic strain of HIV-1 in part because of the fact that virus
engagement of CXCR4 induces signals that lead to cytoskel-
eton reorganization in primary T cells and more efficient virus
infection (Balabanian et al., 2004; Barrero-Villar et al., 2009;
Jime´nez-Baranda et al., 2007; Yoder et al., 2008). Thus, at a
minimum, we anticipated finding changes in the phosphoryla-
tion status of proteins linked to cytoskeletal rearrangements
upon binding of HIV-1 to host cells. Our findings not only sup-
ported this supposition, but also showed that HIV-receptor in-
teractions rapidly modulate phosphorylation of numerous host
cell proteins with the potential to impact multiple steps of viral
replication. Of 1,757 quantified phosphorylation sites, 14%
proved to be HIV responsive. Although some fraction of these
HIV-responsive phosphorylation sites may prove to be false
positives, our analysis only detected a small fraction of total
cellular phosphorylation sites, and we only examined a single
early time point. Thus, it is probable that binding of HIV-1 to
its cell-surface receptors leads to altered phosphorylation of
at least hundreds of host proteins.623, May 15, 2013 ª2013 Elsevier Inc. 619
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Figure 6. HIV-Responsive SR Proteins
Regulate HIV-1 Splicing and Virion Release
(A) Lysates from depleted MAGI cells were
analyzed by immunoblot with each antibody.
(B) Relative quantification of HIV-1 transcripts.
Band intensities of tat and nef alternatively spliced
products (top panel) were divided by tat-1 and nef-
2, respectively, for quantification (bottom panel).
n = 6.
(C) HIV-1 release following depletion of SR pro-
teins as measured by p24 collected on day 5 post
infection. Comparisons were made between each
SRRM2 siRNA and the nontargeting control
siRNA. Bars represent SEM; n = 4; *p < 0.05, **p <
0.01 Mann-Whitney; ns, not significant (p > 0.05).
See also Figure S3.
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blots, analysis of experimentally and computationally derived ki-
nase substrates, and bioinformatics of cellular gene ontologies,
support the validity of the MS-derived phosphorylation site
ratios described here. Fluxes of intracellular calcium were one
of the first and most consistently observed examples of HIV-
induced cellular signaling (Kornfeld et al., 1988; Liu et al., 2000;
Weissman et al., 1997). Calcium activates the CaMK family,
and we detected a strong overrepresentation of CaMKII sub-
strates among upregulated HIV-responsive phosphorylation
sites along with phosphorylation of the transcription factor
ETS-1 (pS282/pS285), a well-characterized substrate of CaMKII
that has been linked to HIV-1 gene expression (Sieweke et al.,
1998; Soderling, 1999; Yang et al., 2009). In addition, overex-
pression of a splice variant of ETS-1 lacking exon VII reactivated
latent HIV-1 (Yang et al., 2009). Interestingly, exon VII contains
serines 282 and 285, and the ETS-1 isoform lacking this exon
binds to DNAmore strongly than wild-type ETS-1 independently
of CaMKII activity (Fisher et al., 1994).
In a previous study, we characterized the CXCL12-responsive
phosphoproteome in a T cell line (Wojcechowskyj et al., 2011),
and the overlap of significantly changed phosphorylation sites
between these data sets was statistically significant (OR: 3.1,
p = 0.039) (Table S4). However, based on the unique nature of
each study and the modest overlap of quantified phosphoryla-
tion sites (50%), it is difficult to determine which of the HIV-
responsive sites were dependent on CXCR4 signaling. To in-
crease the likelihood of capturing relevant signaling events, we
focused on proteins that contained both HIV- and CXCL12-
responsive phosphorylation sites. Suppression of only SRRM2
showed a consistent phenotype on virus replication in both
MAGI and Jurkat cells, whereas MYCBP2, OSBPL11, and
SCYL2 did show effects with some siRNAs. The most consistent620 Cell Host & Microbe 13, 613–623, May 15, 2013 ª2013 Elsevier Inc.of these was with MYCBP2, a negative
regulator of cAMP (Scholich et al.,
2001). Interestingly, our data support the
observations of others that the role of
cAMP during HIV-1 replication is cell
type dependent. In HeLa cells, compo-
nents of PKA signaling enhance HIV-1
replication (Ko¨nig et al., 2008; Lemay
et al., 2008; Zhou et al., 2008), whereasthe opposite is true in Jurkat and primary T cells (Navarro
et al., 1998). Finally, a recent study showed that SCYL2 limits
the release of HIV-1 from cells—something that we did not mea-
sure (Miyakawa et al., 2012).
HIV-1 can disseminate among T cells either through cell-free
or cell-cell routes, and this data set may help elucidate compo-
nents of the cell-cell transmission of HIV-1. The contact between
infected and uninfected CD4 T cells forms structures, termed
‘‘virological synapses’’ (VSs), that resemble immunological syn-
apses (ISs) (Haller and Fackler, 2008). We found several HIV-
responsive phosphoproteins that are known to participate in
either the VS or IS, such as LAT, FYB (ADAP), GRAB2 (Gads),
NCK1, and PTPN6 (SHIP-1). The HIV-responsive phosphopro-
teins APBB1IP (RIAM), RAPGEF6 (rap1 GEF), and SIPA1 (rap1
GAP) are also components of integrin ‘‘inside-out’’ signaling, a
feature of both the VS and IS (Hioe et al., 2011).
Our application of quantitativeMS-based phosphoproteomics
made it possible to explore the possibility that HIV-1 may induce
cellular signals that not only enhance virus entry, but that render
the cell more permissive to later steps in the viral-replication cy-
cle as well. Six SR proteins and five other genes that can regulate
cellular splicing were among the 175 phosphoproteins that were
HIV responsive, raising the possibility that HIV-induced signaling
during entry may influence the splicing of incoming viral tran-
scripts. Indeed, signaling events can regulate the localization,
intrinsic splicing activity, protein-protein interactions, or pro-
tein-RNA interactions of various splicing factors. Tools for firmly
establishing this link are crude, yet this hypothesis is supported
by the fact that five SR proteins and three others were important
for HIV-1 infection and that altered ratios of nef transcripts corre-
lated with p24 release levels. It is also possible that HIV-depen-
dent regulation of these SR proteins is indirect, i.e., that theymay
affect the alternative splicing of additional HIV-1 host factors. In
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during T cell activation (Martinez et al., 2012). Further compli-
cating matters, SR proteins are heavily phosphorylated—over
600 unique phosphorylation sites have been cataloged for
SRm300 alone, making the task of assigning roles for each phos-
phorylation site a daunting one.
At first glance, the kinetic and spatial disconnect between the
plasma membrane and the nucleus in regulating downstream
stages of the HIV-1 life cycle may seem improbable. However,
phosphorylation of cellular proteins during HIV-1 entry can pro-
mote viral gene expression from the provirus (Gringhuis et al.,
2010), and epidermal growth factor induces the phosphorylation
of 62 nuclear phosphorylation sites in HeLa cells within 1 min
(Olsen et al., 2006). In addition, the transcription factors NF-kB
(Briant et al., 1996), NFAT (Cicala et al., 2006), and AP-1 (Briant
et al., 1996; Chirmule et al., 1995), all of which bind to the HIV-
1 long terminal repeat (LTR) and facilitate transcription, localize
into the nucleus upon HIV-1 binding to the cell surface.
The screening approach taken here suggests that the interplay
between HIV-1 and its receptors results in a much broader array
of signaling events than has been suspected and that through
these interactions the virus can modulate the host cell environ-
ment in ways that impact virus replication at multiple steps,
including splicing of viral transcripts. Examining the status of
SRm300 phosphorylation and that of other splicing factors and
phosphoproteins identified in this study over the course of virus
infection in the presence or absence of agents that inhibit virus-
receptor signaling should more fully reveal how the virus can
reprogram cells to make them optimal hosts.
EXPERIMENTAL PROCEDURES
Cell Lines and Viruses
Jurkat E6-1 cells (ATCC) were propagated in RPMI supplemented with 10%
(v/v) fetal bovine serum (FBS). MAGI cells, which are a clone of HeLa cells sta-
bly expressing CD4, CCR5, and b-galactosidase under the control of the HIV-1
LTR, were grown in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% (v/v) FBS. CEM cells were grown in DMEM medium (Athe-
naES) with 10% dialyzed fetal calf serum, and lysine and arginine were
replaced by [13C6,
15N2]-lysine and [
13C6,
15N4]-arginine. Protein isolates
from these cells served as the stable-isotope-labeled reference material for
the SILAC quantitative analyses. The HIV-1 MN strain was used for primary
cell stimulations and was grown in SupT1 cells, purified, concentrated with su-
crose gradients, and inactivated with aldrithiol-2 (AT-2) (Chertova et al., 2003;
Rossio et al., 1998). A mock preparation was produced from uninfected cells
using the same procedures. Replication-incompetent HIV-1 pseudovirions
(pNL43-DEnv-vpr+-luc+) were generated as previously described (Parrish
et al., 2012). The HIV-1 Env strains used for pseudovirion generation were
the lab-adapted X4 strain LAI and the Clade B-transmitted/founded R5 strain
REJO.D12. Replication-competent 89.6 and NL4.3 strains of HIV-1 were
grown in CEMx174 cells and SupT1 cells, respectively.
Primary Human CD4+ T Cell Stimulations
Primary human CD4+ T cells from healthy donors were obtained from the Cen-
ter for AIDS Research Human Immunology Core at the University of Pennsyl-
vania and purified by negative selection against HLA-DR, CD21, CD16,
CD11b, CD14, and CD8. Cells rested overnight in 10% FBS containing
RPMI at 37C and were serum starved for 90 min before stimulation. AT-2-
treated HIV-1 preparations or (volume-matched) mock vesicles were added
to 4.5 3 108 cells (5 3 106 cells/ml) for a final concentration of 20 mg/ml p24.
This concentration of p24 corresponds to approximately 15 nM gp120 and a
multiplicity of infection of 100, a concentration that is commonly used for
biochemical measurements of virus-induced signaling events. After 1 min in-Cell Hcubation at 37C, two volumes of ice-cold PBS containing phosphatase inhib-
itors (Sigma-Aldrich) were added to each culture of cells, whichwere then spun
at 450 3 g at 4C. Supernatant was aspirated, and cell pellets were frozen in
liquid nitrogen.
MS and Data Processing
Details of sample preparation and enrichment, MS, sequence database
searching, mixture-model calculations, and statistical analyses are included
in Supplemental Experimental Procedures.
Immunoblot Analysis
Cell pellets were lysed in 1% Triton X-100 with phosphatase (Sigma-Aldrich
P5726 and P0044) and protease (Roche 1836170) inhibitors for 5 min on ice,
then centrifuged at 20,000 3 g for 10 min. Samples were denatured and
reduced, incubated at 70C for 10 min, then run on 10% Bis-Tris gels. Gels
were transferred to polyvinylidene fluoride membranes and blocked for
30 min in evaporated milk. Blots were incubated at 4C overnight with a
1:1,000 dilution of primary antibodies. Antibodies for ERK1/2 (pT202/pY204),
ERK1/2, a-tubulin, p38 (pT180/pY182), p38, and PPIG were obtained from
Cell Signaling Technology; ETS-1 (pS282/pS285) and ETS-1 from Invitrogen;
MYCPB2, SCYL2, PNN, and ACIN1 from Abcam; OSBPL11 and TRA2A
from Sigma-Aldrich; GAPDH from Calbiochem; SRRM1 from Proteintech;
and SRm300 (B4A11) was a generous gift from Jeff Nickerson.
RNA Interference
Jurkat cells were transfected with an Amaxa nucleofector (Lonza) as follows:
23 106 cells were resuspended in 100 ml solution V containing 100 mM siRNA,
electroporated with program X-001, then incubated in 4 ml of complete RPMI
for 48 hr before harvesting for immunoblot or infection with HIV-1. MAGI cells
were transfected with Lipofectamine RNAiMax Reagent (Invitrogen). We
reverse-transfected 2.5 3 103 cells in a 96-well plate with 50 nM (final) siRNA
according to the manufacturer’s instructions. Cells were then harvested for
immunoblot or infected with HIV-1 72 hr later. siRNA sequences are listed in
Tables S7 and S9.
HIV-1 Infections
Approximately 53 105 nucleofected Jurkat cells were spinoculated with pseu-
dovirions at 1,200 3 g for 2 hr at room temperature. Cells were harvested for
firefly luciferase expression 48 hr post infection (hpi). For infection of MAGI
cells for RT-PCR splicing analysis, 100 ng p24 of either NL4.3 or 89.6 was
added per 1 3 106 cells, rinsed following a 2 hr incubation at 37C, then har-
vested for fluorescence-activated cell sorting (FACS) or RNA 48 hpi. For
b-galactosidase-based infections of MAGI cells, siRNA-treated cells in 96
wells were infected with 2.5 ng p24 per well of replication-competent IMC of
NL4.3, 89.6, and SF162, and b-galactosidase activity was measured 48 hr
later. For measurement of percent infected cells, infected MAGI cells were
stained for intracellular p24 and analyzed by FACS. For p24 release, siRNA-
treated MAGI cells were infected with NL4.3 and 89.6 as above, media
replaced, and collected 5 days later. Supernatant p24 was measured using
AlphaLISA (PerkinElmer) in 384-well plates.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, R
code for themixture model, three figures, and ten tables and can be foundwith
this article online at http://dx.doi.org/10.1016/j.chom.2013.04.011.
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